RNA-Seq Data Mining: Downregulation of NeuroD6 Serves as a Possible Biomarker for Alzheimer's Disease Brains

Alzheimer's disease (AD) is the most common cause of dementia worldwide with no curative therapies currently available. Previously, global transcriptome analysis of AD brains by microarray failed to identify the set of consistently deregulated genes for biomarker development of AD. Therefore, the molecular pathogenesis of AD remains largely unknown. Whole RNA sequencing (RNA-Seq) is an innovative technology for the comprehensive transcriptome profiling on a genome-wide scale that overcomes several drawbacks of the microarray-based approach. To identify biomarker genes for AD, we analyzed a RNA-Seq dataset composed of the comprehensive transcriptome of autopsized AD brains derived from two independent cohorts. We identified the core set of 522 genes deregulated in AD brains shared between both, compared with normal control subjects. They included downregulation of neuronal differentiation 6 (NeuroD6), a basic helix-loop-helix (bHLH) transcription factor involved in neuronal development, differentiation, and survival in AD brains of both cohorts. We verified the results of RNA-Seq by analyzing three microarray datasets of AD brains different in brain regions, ethnicities, and microarray platforms. Thus, both RNA-Seq and microarray data analysis indicated consistent downregulation of NeuroD6 in AD brains. These results suggested that downregulation of NeuroD6 serves as a possible biomarker for AD brains.

[1]  R. Squitti,et al.  Low-copper diet as a preventive strategy for Alzheimer's disease , 2014, Neurobiology of Aging.

[2]  S. Rosenthal,et al.  Late-Onset Alzheimer’s Disease Genes and the Potentially Implicated Pathways , 2014, Current Genetic Medicine Reports.

[3]  Erick R. Scott,et al.  Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease , 2013, Nature.

[4]  Susumu Goto,et al.  Data, information, knowledge and principle: back to metabolism in KEGG , 2013, Nucleic Acids Res..

[5]  Chadwick M. Hales,et al.  U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer’s disease , 2013, Proceedings of the National Academy of Sciences.

[6]  Tomio Sasaki,et al.  Altered Expression of Diabetes-Related Genes in Alzheimer's Disease Brains: The Hisayama Study , 2013, Cerebral cortex.

[7]  A. Singleton,et al.  TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.

[8]  Klaus-Armin Nave,et al.  Neuronal Basic Helix–Loop–Helix Proteins Neurod2/6 Regulate Cortical Commissure Formation before Midline Interactions , 2013, The Journal of Neuroscience.

[9]  M. Rattray,et al.  Gene expression profiling in human neurodegenerative disease , 2012, Nature Reviews Neurology.

[10]  Ole A. Andreassen,et al.  A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline , 2012, Nature.

[11]  J. Kleinman,et al.  Spatiotemporal transcriptome of the human brain , 2011, Nature.

[12]  J. N. Kay,et al.  NEUROD6 EXPRESSION DEFINES NOVEL RETINAL AMACRINE CELL SUBTYPES AND REGULATES THEIR FATE , 2011, Nature Neuroscience.

[13]  J. Kril,et al.  Understanding the pathogenesis of Alzheimer’s disease: will RNA‐Seq realize the promise of transcriptomics? , 2011, Journal of neurochemistry.

[14]  M. Uittenbogaard,et al.  The neurogenic basic helix–loop–helix transcription factor NeuroD6 confers tolerance to oxidative stress by triggering an antioxidant response and sustaining the mitochondrial biomass , 2010, ASN neuro.

[15]  B. Spann,et al.  Transcriptome Analysis of Synaptoneurosomes Identifies Neuroplasticity Genes Overexpressed in Incipient Alzheimer's Disease , 2009, PloS one.

[16]  Y. Nakano,et al.  Prg1 is regulated by the basic helix‐loop‐helix transcription factor Math2 , 2008, Journal of neurochemistry.

[17]  Winnie S. Liang,et al.  Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons , 2008, Proceedings of the National Academy of Sciences.

[18]  James J. Chen,et al.  Reproducibility of microarray data: a further analysis of microarray quality control (MAQC) data , 2007, BMC Bioinformatics.

[19]  V. Haroutunian,et al.  Gene Expression Alterations in the Sphingolipid Metabolism Pathways during Progression of Dementia and Alzheimer’s Disease: A Shift Toward Ceramide Accumulation at the Earliest Recognizable Stages of Alzheimer’s Disease? , 2007, Neurochemical Research.

[20]  H. Braak,et al.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.

[21]  L. Fratiglioni,et al.  Role of genes and environments for explaining Alzheimer disease. , 2006, Archives of general psychiatry.

[22]  KouichiC . Nakamura,et al.  Pyramidal neurons of upper cortical layers generated by NEX-positive progenitor cells in the subventricular zone. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Uittenbogaard,et al.  The basic helix‐loop‐helix transcription factor Nex‐1/Math‐2 promotes neuronal survival of PC12 cells by modulating the dynamic expression of anti‐apoptotic and cell cycle regulators , 2005, Journal of neurochemistry.

[24]  W. Markesbery,et al.  Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Uittenbogaard,et al.  The basic helix‐loop‐helix differentiation factor Nex1/MATH‐2 functions as a key activator of the GAP‐43 gene , 2003, Journal of neurochemistry.

[26]  M. Ball,et al.  Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down‐regulation and up‐regulation of apoptotic and pro‐inflammatory signaling , 2002, Journal of neuroscience research.

[27]  M. Uittenbogaard,et al.  Constitutive overexpression of the basic helix‐loop‐helix Nex1/MATH‐2 transcription factor promotes neuronal differentiation of PC12 cells and neurite regeneration , 2002, Journal of neuroscience research.

[28]  J. Trojanowski,et al.  Expression profile of transcripts in Alzheimer's disease tangle‐bearing CA1 neurons , 2000, Annals of neurology.

[29]  M. Frotscher,et al.  Neuronal Basic Helix-Loop-Helix Proteins (NEX and BETA2/Neuro D) Regulate Terminal Granule Cell Differentiation in the Hippocampus , 2000, The Journal of Neuroscience.

[30]  K. Nave,et al.  Neuronal Basic Helix-loop-helix Proteins (nex, Neurod, Ndrf): Spatiotemporal Expression and Targeted Disruption of the Nex Gene in Transgenic Mice , 2000 .

[31]  K. Nave,et al.  NEX-1: a novel brain-specific helix-loop-helix protein with autoregulation and sustained expression in mature cortical neurons , 1994, Mechanisms of Development.

[32]  J. Walton,et al.  Aluminum involvement in the progression of Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[33]  M. Gerstein,et al.  RNA-Seq: a revolutionary tool for transcriptomics , 2009, Nature Reviews Genetics.

[34]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.